Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Tuesday July 2, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, discuss HCC highlights from ASCO 2019.

Featured Videos

Robert L. Coleman, MD, FACOG, FACS, on how veliparib factors into ovarian cancer treatment

Dennis J. Slamon, MD, PhD, on the significance of the phase III MONALEESA-3 trial

Shirish M. Gadgeel MBBS, speculates on the future of RET-altered NSCLC